SBIR/STTR Research Award

Targets of Acquired Tick-Resistance As Anti-Tick Vaccines

Award identifier df93f5966dd41a461d82d922091028225dc4c2a287c82953360d411d2e31d33dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$596,625

Program and phase

STTR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
L2 DIAGNOSTICS LLC
Proposal award date
2019-07-01
Contract end date
2021-06-30
UEI
GKA7VH5LFR25
Solicitation number
PA18-575
Topic code
NIAID

Research abstract

ABSTRACTThis proposal seeks to develop a novel vaccine against pathogens transmitted by the blacklegged tick, Ixodes scapularis, by targeting tick salivary proteins (Salps) critical for tick feeding. I. scapularis Salps provide functions critical for evading host defense responses detrimental to the tick. Further, these salivary functions are also co-opted by tick-transmitted pathogens to ensure their survival in the host. We reason that tick Salps critical for tick feeding might serve as vaccine targets to impair tick feeding and consequently, also thwart the transmission of multiple tick-borne pathogens.Our hypothesis is validated by the phenomenon of acquired tick-resistance wherein, upon repeated tick infestations non-permissive hosts such as rabbits, and guinea pigs mount a robust immune response against tick Salps critical for tick feeding and this results in rapid rejection of ticks. Tick-resistance has also been shown to prevent transmission of B. burgdorferi. Exploiting this phenomenon, we have identified several Salps that are avidly recognized by tick-resistant animal sera.Since tick-resistant sera recognize multiple Salps it is reasonable to expect that multiple immunodominant Salps might have to be targeted simultaneously to recapitulate tick-resistance and achieve robust tick rejection. In this research study, we will:1. Assess the vaccine potential of a combination of immunodominant Salps to prevent tick feeding in conjunction with adjuvants approved for human use.2. Examine the utility of simultaneously targeting multiple immunodominant tick Salps to prevent the transmission of two tick-transmitted pathogens, B. burgdorferi and A. phagocytophilum.This combination strategy targeting multiple Salps simultaneously has the potential to result in a vaccine that might block the transmission of multiple I. scapularis- borne pathogens.NARRATIVE This Phase I proposal will develop a novel anti-I. scapularis vaccine by targeting immunodominant tick salivary protein antigens to prevent tick feeding and consequently impair the transmission of multiple I. scapularis-transmitted pathogens.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

84 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $45,551,124. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.